Scientific publications for BioPredictive non-invasive diagnostics

Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease.

Ivancovsky-Wajcman D et al. · Dig Liver Dis · 2019 Match 100

…The upper tertile of vitamin C intake/1000 Kcal was associated with…

FibroTest NashTest SteatoTest Metabolic

Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis.

Terrier B et al. · J Hepatol · 2011 Match 98

### Background & Aims Recent findings in hepatitis C virus (HCV)-monoinfected patients have…

ActiTest FibroTest HCV HIV

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.

European Association for the Study of the Liver (EASL) et al. · Obes Facts · 2016 Match 96

FibroTest SteatoTest Metabolic

Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action. Review

Bril F et al. · Diabetes Care · 2017 Match 93

Traditionally a disease of hepatologists, nonalcoholic fatty liver disease (NAFLD) has recently…

FibroTest Metabolic

A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis.

Ratziu V et al. · J Hepatol · 2011 Match 91

### Background & Aims Nonalcoholic steatohepatitis (NASH) is a prevalent liver disease associated with…

FibroTest Metabolic

Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters?

Gentile I et al. · Infez Med · 2014 Match 89

It is estimated that hepatitis C virus (HCV) infects chronically about 160…

FibroTest HCV

An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Key publication

Myers RP et al. · Can J Gastroenterol · 2012 Match 86

Chronic hepatitis C remains a significant medical and economic burden in Canada…

FibroTest HCV

Silymarin in non alcoholic fatty liver disease.

Cacciapuoti F et al. · World J Hepatol · 2013 Match 84

### Aim This study was undertaken to evaluate the hepatic effects of silybum…

SteatoTest Metabolic

Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection.

Poynard T et al. · Ann Intern Med · 2013 Match 81

FibroTest HCV

Comparison of Fibrotest and PGAA for the diagnosis of fibrosis stage in patients with alcoholic liver disease.

Naveau S et al. · Eur J Gastroenterol Hepatol · 2014 Match 79

### Background And Aims The PGAA index was one of the first composite…

FibroTest Alcohol

Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease.

Viglino D et al. · Sci Rep · 2018 Match 77

Chronic Obstructive Pulmonary Disease (COPD) and Non-Alcoholic Fatty Liver Disease (NAFLD…

FibroTest NashTest SteatoTest Metabolic

Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.

Jullian-Desayes I et al. · Respirology · 2016 Match 74

### Background And Objective Obstructive sleep apnoea (OSA) could be an independent risk…

NashTest SteatoTest Metabolic

Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.

Zarski JP et al. · Liver Int · 2010 Match 72

…responder patients with chronic hepatitis C has been essentially evaluated by histological…

ActiTest FibroTest HCV

Prediction for steatosis in type-2 diabetes: clinico-biological markers versus 1H-MR spectroscopy.

Guiu B et al. · Eur Radiol · 2012 Match 70

### Objectives The SteatoTest, fatty liver index (FLI) and hepatic steatosis index (HSI…

SteatoTest Metabolic

Hepatoprotective Effect of Antrodia cinnamomea Mycelium in Patients with Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial.

Chiou YL et al. · J Am Coll Nutr · 2021 Match 67

### Objective Nonalcoholic steatohepatitis (NASH) has become a prominent liver disease in contemporary…

ActiTest FibroTest SteatoTest Metabolic

Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis.

Friedrich-Rust M et al. · J Cyst Fibros · 2013 Match 65

### Background Patients with cystic fibrosis (CF) have a relevant morbidity and mortality…

FibroTest Other

Non-invasive diagnosis and biomarkers in alcohol-related liver disease. Review

Moreno C et al. · J Hepatol · 2019 Match 62

Even though alcohol-related liver disease (ALD) is a major cause of…

FibroTest Alcohol

Novel Biomarkers of Grade I Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease.

Braha A et al. · J Clin Med · 2024 Match 60

**Background/Objectives**: Prior research has identified a significant association between heart disease…

FibroTest Metabolic

Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants.

López Tórrez SM et al. · Front Nutr · 2024 Match 58

### Introduction A prognostic model to predict liver severity in people with metabolic…

FibroTest Metabolic

Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19.

Deckmyn O et al. · Biomedicines · 2022 Match 55

In patients with non-alcoholic fatty liver disease (NAFLD) with or without…

FibroTest Metabolic

Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.

Stevenson M et al. · Health Technol Assess · 2012 Match 53

### Background Excessive alcohol consumption may lead to the development of alcohol-related…

FibroTest Alcohol